News

The Manila Times
manilatimes. net > 06/25/2026 > tmt-newswire > globenewswire > acrow-modular-bridge-supports-major-expansion-at-bristol-airport > 2373130

Acrow Modular Bridge Supports Major Expansion at Bristol Airport

4+ hour, 8+ min ago  (419+ words) Acrow Bridge a leading international bridge engineering and supply company, announced today one of its modular steel bridges has been installed to support ongoing construction works at Bristol Airport. .. Acrow Modular Bridge Supports Major Expansion at Bristol Airport Temporary installation…...

Symbols: lloy.l,shel.l,btc-usd,inc.aq,0a9N.0,srvl.aq
The Manila Times
manilatimes. net > 04/23/2026 > tmt-newswire > globenewswire > greenwich-lifesciences-announces-acceptance-of-abstract-at-asco-2026 > 2326881

Greenwich Life Sciences Announces Acceptance of Abstract at ASCO 2026

2+ mon, 2+ day ago  (90+ words) The 2026 ASCO Annual Meeting will be held from May 28 to June 2, 2026. The full text of the abstract and poster will be available on June 1, 2026, the day of the presentation. In addition to ASCO, the Company plans to attend ESMO Breast,…...

Symbols: btc-usd,nasdaq:annx,nasdaq:glsi
The Manila Times
manilatimes. net > 04/23/2026 > tmt-newswire > globenewswire > greenwich-lifesciences-announces-receipt-of-nasdaq-notice-regarding-late-form-10-k-filing > 2326562

Greenwich Life Sciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing

2+ mon, 3+ day ago  (462+ words) STAFFORD, Texas, April 22, 2026 (GLOBE NEWSWIRE) -- Greenwich Life Sciences, Inc. (Nasdaq: GLSI) (the 'Company'), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated GLSI-100, an immunotherapy to prevent breast cancer recurrences, today…...

Symbols: nasdaq:vtgn
The Manila Times
manilatimes. net > 04/15/2026 > tmt-newswire > globenewswire > gonetspeed-powers-up-bristol-again > 2321102

Go Netspeed Powers Up Bristol, Again

2+ mon, 1+ week ago  (535+ words) The Manila Times Go Netspeed Powers Up Bristol, Again Bristol's multigigabit network grows with $4 M expansion BRISTOL, Conn. , April 15, 2026 (GLOBE NEWSWIRE) -- Go Netspeed, the Northeast's largest independent fiber builder, is expanding its 100% fiber network in Bristol, bringing high-speed internet access…...

The Manila Times
manilatimes. net > 03/17/2026 > tmt-newswire > globenewswire > greenwich-lifesciences-provides-update-showing-continued-reduction-in-recurrence-rate-in-the-open-label-arm-of-flamingo-01 > 2301523

Greenwich Life Sciences Provides Update Showing Continued Reduction in Recurrence Rate in the Open Label Arm of FLAMINGO-01

3+ mon, 1+ week ago  (629+ words) STAFFORD, Texas, March 17, 2026 (GLOBE NEWSWIRE) -- Greenwich Life Sciences, Inc. (Nasdaq: GLSI) (the 'Company'), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today provided a preliminary…...

Symbols: glsi
The Manila Times
manilatimes. net > 10/15/2025 > tmt-newswire > globenewswire > fieldpoint-private-announces-new-office-in-greenwich-connecticut > 2200775

Fieldpoint Private Announces New Office in Greenwich, Connecticut

8+ mon, 1+ week ago  (139+ words) Convenient ground-level office near Greenwich Avenue at 130 Mason Street to open October 15 GREENWICH, Conn. , Oct. 14, 2025 (GLOBE NEWSWIRE) -- Fieldpoint Private announced today that it will open a new office at 130 Mason Street, Suite 102, in Greenwich's historic downtown shopping district, on October…...

The Manila Times
manilatimes. net > 09/08/2025 > tmt-newswire > globenewswire > first-disclosure-of-global-interim-phase-2-data-for-biontech-and-bristol-myers-squibb-pd-l1xvegf-a-bispecific-antibody-pumitamig-bnt327bms986545-in-patients-with-extensive-stage-small-cell-lung-cancer-shows-encouraging-antitumor-activity > 2180852

First Disclosure of Global Interim Phase 2 Data for Bio NTech and Bristol Myers Squibb PD-L1x VEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

9+ mon, 2+ week ago  (119+ words) About the BNT327-01 Phase 2 clinical trial About Small Cell Lung Cancer About pumitamig (also known as BNT327 or BMS986545) About Bristol Myers Squibb Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help…...

The Manila Times
manilatimes. net > 08/27/2025 > tmt-newswire > globenewswire > dutch-miller-nissan-of-bristol-launches-no-addendum-no-markup-policy-redefining-the-car-buying-experience > 2174350

Dutch Miller Nissan of Bristol Launches 'No Addendum, No Markup" Policy, Redefining the Car Buying Experience

9+ mon, 4+ week ago  (259+ words) Bristol, TN, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Dutch Miller Nissan of Bristol has announced its groundbreaking new approach to retailing: a No Addendum, No Markup policy on all new vehicles. Serving customers from the Tri-Cities, East Tennessee, Virginia, Kentucky, and North Carolina,…...